Glycan-dependent immunogenicity of recombinant soluble trimeric hemagglutinin

Journal of Virology

Volumn 86, Issue 21, 2012, Pages 11735-11744

  de Vries, Robert P ^a,h   Smit, Cornelis H ^b   de Bruin, Erwin ^c   Rigter, Alan ^a   de Vries, Erik ^a   Cornelissen, Lisette A H M ^d   Eggink, Dirk ^e,i   Chung, Nancy P Y ^f   Moore, John P ^f   Sanders, Rogier W ^e,f   Hokke, Cornelis H ^b   Koopmans, Marion ^c,g   Rottier, Peter J M ^a   de Haan, Cornelis A M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d WAGENINGEN UNIVERSITY   (Netherlands)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f UTRECHT UNIVERSITY   (Netherlands)

^g ERASMUS MEDICAL CENTER   (Netherlands)

^h SCRIPPS RESEARCH INSTITUTE   (United States)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOGLYCOSIDASE H; GLYCAN; GLYCOSIDASE; HEMAGGLUTINATION INHIBITING ANTIBODY; INFLUENZA VIRUS HEMAGGLUTININ; KIFUNENSINE; N ACETYLGLUCOSAMINE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHICKEN; CONTROLLED STUDY; EMBRYO; FEMALE; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; INSECT CELL; MAMMAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION;

ANIMALS; ANTIBODIES, VIRAL; CELL LINE; CHICKENS; ELECTROPHORESIS; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININS; HUMANS; INFLUENZA A VIRUS; INSECTS; MASS SPECTROMETRY; MICE; MICE, INBRED C57BL; POLYSACCHARIDES; RECOMBINANT PROTEINS;

GALLUS GALLUS; HEXAPODA; INFLUENZA A VIRUS; MUS;

EID: 84869171979     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01084-12     Document Type: Article

References (37)

1. Banerjee K, et al. 2009. Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo. Virology 389:108-121.
2. Banerjee K, et al. 2012. Occluding the mannose moieties on human immunodeficiency virus type 1 gp120 with griffithsin improves the antibody responses to both proteins in mice. AIDS Res. Hum. Retroviruses 28:206-214.
3. Bohne-Lang A, von der Lieth CW. 2005. GlyProt: in silico glycosylation of proteins. Nucleic Acids Res. 33:W214-W219.
4. Bosch BJ, et al. 2010. Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets. J. Virol. 84:10366 -10374.
5. Cornelissen LA, et al. 2010.Asingle immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1. PLoS One 5:e10645. doi:10.1371/journal.pone.0010645.
6. Das SR, et al. 2011. Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy. Proc. Natl. Acad. Sci. U.S.A. 108:E1417-E1422. doi:10.1073/pnas.1108754108.
7. Das SR, et al. 2010. Glycosylation focuses sequence variation in the influenza A virus H1 hemagglutinin globular domain. PLoS Pathog. 6:e1001211. doi:10.1371/journal.ppat.1001211.
8. Deshpande KL, Fried VA, Ando M, Webster RG. 1987. Glycosylation affects cleavage of an H5N2 influenza virus hemagglutinin and regulates virulence. Proc. Natl. Acad. Sci. U.S.A. 84:36-40.
9. de Vries RP, et al. 2010. The influenza A virus hemagglutinin glycosylation state affects receptor-binding specificity. Virology 403:17-25.
10. Durocher Y, Butler M. 2009. Expression systems for therapeutic glycoprotein production. Curr. Opin. Biotechnol. 20:700 -707.
11. Elbein AD, Tropea JE, Mitchell M, Kaushal GP. 1990. Kifunensine, a potent inhibitor of the glycoprotein processing mannosidase I. J. Biol.Chem. 265:15599 -15605.
12. Ellebedy AH, Webby RJ. 2009. Influenza vaccines. Vaccine 27(Suppl. 4):D65-D68.
13. Hanson SR, et al. 2009. The core trisaccharide of an N-linked glycoprotein intrinsically accelerates folding and enhances stability. Proc. Natl.Acad. Sci. U.S.A. 106:3131-3136.
14. Kim YK, et al. 2005. Production and N-glycan analysis of secreted human erythropoietin glycoprotein in stably transfected Drosophila S2 cells. Biotechnol.Bioeng. 92:452- 461.
15. Koopmans M, et al. 2012. Profiling of humoral immune responses to influenza viruses by using protein microarray. Clin. Microbiol. Infect.18:797- 807.
16. Lee SJ, et al. 2002. Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science 295:1898 -1901.
17. Loeffen WL, et al. 2011. Vaccination with a soluble recombinant hemagglutinin trimer protects pigs against a challenge with pandemic (H1N1)2009 influenza virus. Vaccine 29:1545-1550.
18. Maley F, Trimble RB, Tarentino AL, Plummer TH, Jr. 1989. Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases. Anal. Biochem. 180:195-204.
19. Martinelli E, et al. 2007. HIV-1 gp120 inhibits TLR9-mediated activation and IFN-{alpha} secretion in plasmacytoid dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 104:3396 -3401.
20. Munk K, et al. 1992. Carbohydrate masking of an antigenic epitope of influenza virus haemagglutinin independent of oligosaccharide size. Glycobiology 2:233-240.
21. Ohuchi M, Ohuchi R, Feldmann A, Klenk HD. 1997. Regulation of receptor binding affinity of influenza virus hemagglutinin by its carbohydrate moiety. J. Virol. 71:8377- 8384.
22. Ohuchi M, Ohuchi R, Matsumoto A. 1999. Control of biological activities of influenza virus hemagglutinin by its carbohydrate moiety. Microbiol.Immunol. 43:1071-1076.
23. Osterhaus A, Fouchier R, Rimmelzwaan G. 2011. Towards universal influenza vaccines? Philos. Trans. R. Soc. Lond. B Biol. Sci. 366:2766-2773.
24. Pejchal R, et al. 2011. A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. Science 334:1097-1103.
25. Reading PC, Tate MD, Pickett DL, Brooks AG. 2007. Glycosylation as a target for recognition of influenza viruses by the innate immune system.Adv. Exp. Med. Biol. 598:279 -292.
26. Reeves PJ, Callewaert N, Contreras R, Khorana HG. 2002. Structure and function in rhodopsin: high-level expression of rhodopsin with restricted and homogeneous N-glycosylation by a tetracycline-inducible Nacetylglucosaminyltransferase I-negative HEK293S stable mammalian cell line. Proc. Natl. Acad. Sci. U.S.A. 99:13419 -13424.
27. Ruhaak LR, Steenvoorden E, Koeleman CA, Deelder AM, Wuhrer M.2010. 2-Picoline-borane: a non-toxic reducing agent for oligosaccharide labeling by reductive amination. Proteomics 10:2330 -2336.
28. Safdar A, Cox MM. 2007. Baculovirus-expressed influenza vaccine. A novel technology for safe and expeditious vaccine production for human use. Expert Opin. Investig. Drugs 16:927-934.
29. Schmidt TG, Skerra A. 2007. The Strep-tag system for one-step purification and high-affinity detection or capturing of proteins. Nat. Protoc.2:1528 -1535.
30. Shan M, et al. 2007. HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells. PLoS Pathog. 3:e169. doi:10.1371/journal.ppat.0030169.
31. Skehel JJ, et al. 1984. A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody.Proc. Natl. Acad. Sci. U.S.A. 81:1779 -1783.
32. van Liempt E, et al. 2006. Specificity of DC-SIGN for mannose- and fucose-containing glycans. FEBS Lett. 580:6123- 6131.
33. Vigerust DJ, et al. 2007. N-linked glycosylation attenuates H3N2 influenza viruses. J. Virol. 81:8593- 8600.
34. Wang CC, et al. 2009. Glycans on influenza hemagglutinin affect receptor binding and immune response. Proc. Natl. Acad. Sci. U.S.A. 106:18137-18142.
35. Wang SF, et al. 2008. DC-SIGN mediates avian H5N1 influenza virus infection in cis and in trans. Biochem. Biophys. Res. Commun. 373:561-566.
36. Wei CJ, et al. 2008. Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus. J. Virol. 82:6200-6208.
37. Weldon WC, et al. 2010. Enhanced immunogenicity of stabilized trimeric soluble influenza hemagglutinin. PLoS One 5:e12466. doi:10.1371/journal.pone.0012466.